IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-50138-x.html
   My bibliography  Save this article

Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer

Author

Listed:
  • Xiaojun Zhou

    (Wuhan University
    Wuhan University)

  • Genxin Wang

    (Wuhan University
    Wuhan University)

  • Chenhui Tian

    (Wuhan University
    Wuhan University)

  • Lin Du

    (Wuhan University
    Wuhan University)

  • Edward V. Prochownik

    (Children’s Hospital of Pittsburgh of UPMC
    Department of Microbiology and Molecular Genetics of UPMC
    The Hillman Cancer Institute of UPMC)

  • Youjun Li

    (Wuhan University
    Wuhan University)

Abstract

Tumor cells reprogram their metabolism to produce specialized metabolites that both fuel their own growth and license tumor immune evasion. However, the relationships between these functions remain poorly understood. Here, we report CRISPR screens in a mouse model of colo-rectal cancer (CRC) that implicates the dual specificity phosphatase 18 (DUSP18) in the establishment of tumor-directed immune evasion. Dusp18 inhibition reduces CRC growth rates, which correlate with high levels of CD8+ T cell activation. Mechanistically, DUSP18 dephosphorylates and stabilizes the USF1 bHLH-ZIP transcription factor. In turn, USF1 induces the SREBF2 gene, which allows cells to accumulate the cholesterol biosynthesis intermediate lanosterol and release it into the tumor microenvironment (TME). There, lanosterol uptake by CD8+ T cells suppresses the mevalonate pathway and reduces KRAS protein prenylation and function, which in turn inhibits their activation and establishes a molecular basis for tumor cell immune escape. Finally, the combination of an anti-PD-1 antibody and Lumacaftor, an FDA-approved small molecule inhibitor of DUSP18, inhibits CRC growth in mice and synergistically enhances anti-tumor immunity. Collectively, our findings support the idea that a combination of immune checkpoint and metabolic blockade represents a rationally-designed, mechanistically-based and potential therapy for CRC.

Suggested Citation

  • Xiaojun Zhou & Genxin Wang & Chenhui Tian & Lin Du & Edward V. Prochownik & Youjun Li, 2024. "Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50138-x
    DOI: 10.1038/s41467-024-50138-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-50138-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-50138-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Demin Cai & Junjian Wang & Bei Gao & Jin Li & Feng Wu & June X. Zou & Jianzhen Xu & Yuqian Jiang & Hongye Zou & Zenghong Huang & Alexander D. Borowsky & Richard J. Bold & Primo N. Lara & Jian Jian Li , 2019. "RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype," Nature Communications, Nature, vol. 10(1), pages 1-17, December.
    2. Christina K. Baumgartner & Hakimeh Ebrahimi-Nik & Arvin Iracheta-Vellve & Keith M. Hamel & Kira E. Olander & Thomas G. R. Davis & Kathleen A. McGuire & Geoff T. Halvorsen & Omar I. Avila & Chirag H. P, 2023. "The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity," Nature, Nature, vol. 622(7984), pages 850-862, October.
    3. Gabriela Popescu & Antoine Robert & James R. Howe & Anthony Auerbach, 2004. "Reaction mechanism determines NMDA receptor response to repetitive stimulation," Nature, Nature, vol. 430(7001), pages 790-793, August.
    4. Xinjian Liu & Xuhui Bao & Mengjie Hu & Hanman Chang & Meng Jiao & Jin Cheng & Liyi Xie & Qian Huang & Fang Li & Chuan-Yuan Li, 2020. "Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer," Nature, Nature, vol. 588(7839), pages 693-698, December.
    5. Tongzhou Li & Yandong Yin & Zhiwei Zhou & Jiaqian Qiu & Wenbin Liu & Xueting Zhang & Kaiwen He & Yuping Cai & Zheng-Jiang Zhu, 2021. "Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    6. Xiujie Sun & Bogang Wu & Huai-Chin Chiang & Hui Deng & Xiaowen Zhang & Wei Xiong & Junquan Liu & Aaron M. Rozeboom & Brent T. Harris & Eline Blommaert & Antonio Gomez & Roderic Espin Garcia & Yufan Zh, 2021. "Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion," Nature, Nature, vol. 599(7886), pages 673-678, November.
    7. Wei Yang & Yibing Bai & Ying Xiong & Jin Zhang & Shuokai Chen & Xiaojun Zheng & Xiangbo Meng & Lunyi Li & Jing Wang & Chenguang Xu & Chengsong Yan & Lijuan Wang & Catharine C. Y. Chang & Ta-Yuan Chang, 2016. "Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism," Nature, Nature, vol. 531(7596), pages 651-655, March.
    8. David W. Morgens & Michael Wainberg & Evan A. Boyle & Oana Ursu & Carlos L. Araya & C. Kimberly Tsui & Michael S. Haney & Gaelen T. Hess & Kyuho Han & Edwin E. Jeng & Amy Li & Michael P. Snyder & Will, 2017. "Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens," Nature Communications, Nature, vol. 8(1), pages 1-8, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wenfeng Ren & Zilong Xu & Yating Chang & Fei Ju & Hongning Wu & Zhiqi Liang & Min Zhao & Naizhen Wang & Yanhua Lin & Chenhang Xu & Shengming Chen & Yipeng Rao & Chaolong Lin & Jianxin Yang & Pingguo L, 2024. "Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Yu Feng & Wenjuan Ma & Yupeng Zang & Yanying Guo & Young Li & Yixuan Zhang & Xuan Dong & Yi Liu & Xiaojuan Zhan & Zhizhong Pan & Mei Luo & Miaoqing Wu & Ao Chen & Da Kang & Gong Chen & Longqi Liu & Ji, 2024. "Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    3. Wanzun Lin & Li Chen & Haojiong Zhang & Xianxin Qiu & Qingting Huang & Fangzhu Wan & Ziyu Le & Shikai Geng & Anlan Zhang & Sufang Qiu & Long Chen & Lin Kong & Jiade J. Lu, 2023. "Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    4. Shiqun Wang & Wei Yan & Lingkai Kong & Shuguang Zuo & Jingyi Wu & Chunxiao Zhu & Huaping Huang & Bohao He & Jie Dong & Jiwu Wei, 2023. "Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    5. Miguel M. Álvarez & Josep Biayna & Fran Supek, 2022. "TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    6. Xiaolong Cheng & Zexu Li & Ruocheng Shan & Zihan Li & Shengnan Wang & Wenchang Zhao & Han Zhang & Lumen Chao & Jian Peng & Teng Fei & Wei Li, 2023. "Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    7. Shuling Xu & Zhijun Zhu & Daniel G. Delafield & Michael J. Rigby & Gaoyuan Lu & Megan Braun & Luigi Puglielli & Lingjun Li, 2024. "Spatially and temporally probing distinctive glycerophospholipid alterations in Alzheimer’s disease mouse brain via high-resolution ion mobility-enabled sn-position resolved lipidomics," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    8. Florian Eberhardt & Andreas V M Herz & Stefan Häusler, 2019. "Tuft dendrites of pyramidal neurons operate as feedback-modulated functional subunits," PLOS Computational Biology, Public Library of Science, vol. 15(3), pages 1-23, March.
    9. Mingjiong Zhang & Jiahua Cui & Haoyan Chen & Yifan Cheng & Qiaoyu Chen & Feng Zong & Xiao Lu & Lang Qin & Yu Han & Xingwang Kuai & Yuxing Zhang & Minjie Chu & Shuangshuang Wu & Jianqing Wu, 2025. "Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    10. Zhen Lu & Jinyun Chen & Pengfei Yu & Matthew J. Atherton & Jun Gui & Vivek S. Tomar & Justin D. Middleton & Neil T. Sullivan & Sunil Singhal & Subin S. George & Ashley G. Woolfork & Aalim M. Weljie & , 2022. "Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    11. Guizhen Fan & Mariah R. Baker & Lara E. Terry & Vikas Arige & Muyuan Chen & Alexander B. Seryshev & Matthew L. Baker & Steven J. Ludtke & David I. Yule & Irina I. Serysheva, 2022. "Conformational motions and ligand-binding underlying gating and regulation in IP3R channel," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    12. Chi Chun Wong & Jian-Lin Wu & Fenfen Ji & Wei Kang & Xiqing Bian & Huarong Chen & Lam-Shing Chan & Simson Tsz Yat Luk & Samuel Tong & Jiaying Xu & Qiming Zhou & Dabin Liu & Hao Su & Hongyan Gou & Alvi, 2022. "The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    13. Malgorzata J. Latallo & Shaopeng Wang & Daoyuan Dong & Blake Nelson & Nathan M. Livingston & Rong Wu & Ning Zhao & Timothy J. Stasevich & Michael C. Bassik & Shuying Sun & Bin Wu, 2023. "Single-molecule imaging reveals distinct elongation and frameshifting dynamics between frames of expanded RNA repeats in C9ORF72-ALS/FTD," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    14. Jinsen Zhang & Rui Sun & Yingying Lyu & Chaxian Liu & Ying Liu & Yuan Feng & Minjie Fu & Peter Jih Cheng Wong & Zunguo Du & Tianming Qiu & Yi Zhang & Dongxiao Zhuang & Zhiyong Qin & Yu Yao & Wei Zhu &, 2024. "Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    15. Michael Papanicolaou & Amelia L. Parker & Michelle Yam & Elysse C. Filipe & Sunny Z. Wu & Jessica L. Chitty & Kaitlin Wyllie & Emmi Tran & Ellie Mok & Audrey Nadalini & Joanna N. Skhinas & Morghan C. , 2022. "Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
    16. Jiacheng Lyu & Lin Bai & Yumiao Li & Xiaofang Wang & Zeya Xu & Tao Ji & Hua Yang & Zizheng Song & Zhiyu Wang & Yanhong Shang & Lili Ren & Yan Li & Aimin Zang & Youchao Jia & Chen Ding, 2024. "Plasma proteome profiling reveals dynamic of cholesterol marker after dual blocker therapy," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    17. Anna S. Dickson & Tekle Pauzaite & Esther Arnaiz & Brian M. Ortmann & James A. West & Norbert Volkmar & Anthony W. Martinelli & Zhaoqi Li & Niek Wit & Dennis Vitkup & Arthur Kaser & Paul J. Lehner & J, 2023. "A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesis," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    18. Lianmei Tan & Tao Yin & Handan Xiang & Liuyang Wang & Poorva Mudgal & Junying Chen & Yi Ding & Guoping Wang & Bryan Jian Wei Lim & Yuqi Huang & De Huang & Yaosi Liang & Peter B. Alexander & Kun Xiang , 2024. "Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    19. David M Santucci & Sridhar Raghavachari, 2008. "The Effects of NR2 Subunit-Dependent NMDA Receptor Kinetics on Synaptic Transmission and CaMKII Activation," PLOS Computational Biology, Public Library of Science, vol. 4(10), pages 1-16, October.
    20. Kuo-Sheng Hsu & James M. Dunleavey & Christopher Szot & Liping Yang & Mary Beth Hilton & Karen Morris & Steven Seaman & Yang Feng & Emily M. Lutz & Robert Koogle & Francesco Tomassoni-Ardori & Saurabh, 2022. "Cancer cell survival depends on collagen uptake into tumor-associated stroma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50138-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.